Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

Transient Neurologic Symptoms Clinical Trial

Official title:

Spinal Anesthesia Using Lidocaine and Sufentanil and TNS (=Transient Neurological Symptoms)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01283087
• Other study ID #: 400229
• Status: Completed
• Phase: N/A
• First received: January 21, 2011
• Last updated: November 23, 2017
• Start date: January 2011
• Est. completion date: May 2016

Study information

• Verified date: November 2017
• Source: Vestre Viken Ringerike Sykehus
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 168
• Est. completion date: May 2016
• Est. primary completion date: May 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• adults over the age of seventeen years

Exclusion Criteria:

• patient refuse spinal anesthesia

• spinal anesthesia is contraindicated

• pregnancy

• patient is incapable of giving consent

• diabetes

• neurological disorders

• chronic pain

• chronic use of analgesics

• spinal anesthesia within five days before the actual surgery

Related Conditions & MeSH terms

• Neurologic Manifestations
• Transient Neurologic Symptoms

Locations

Country	Name	City	State
Norway	Ringerike Sykehus	Hønefoss
Norway	Vestre Viken HF Ringerike Sykehus	Hønefoss

Sponsors (1)

Lead Sponsor	Collaborator
Vestre Viken Ringerike Sykehus

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Symptoms of transient neurological symptoms		5 days